Vivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel™
December 02, 2021 09:30 ET
|
Vivos Inc.
Richland WA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), on November 30 Vivos Inc met with the Food and Drug Administration to obtain suggestions on improving the current draft of...
Vivos Inc Announces Johns Hopkins University (Veterinary Clinical Trials Network) is a New Regional Clinic for Isopet®
November 23, 2021 09:30 ET
|
Vivos Inc.
This replaces and corrects the press release from November 22. Johns Hopkins (VCTN) Veterinary Clinical Trials Network is our teaming partner not the Center for Image Guided Animal Therapy (CIGAT). ...
Vivos Inc Announces John Hopkins University as a New Regional Clinic for Isopet®
November 22, 2021 09:30 ET
|
Vivos Inc.
Richland WA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that John Hopkins University Center for Image Guided Animal Therapy (CIGAT) is now an Isopet®...
Vivos Inc Signs a MOU for a New Regional Clinic in NY for IsoPet Therapy
October 18, 2021 09:30 ET
|
Vivos Inc.
Richland WA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it signed a Memorandum of Understanding with the Animal Hospital Surgical Center in East...
Vivos Inc Completes Certification Training Modules for Future IsoPet® Therapy Regional Clinics
September 22, 2021 09:30 ET
|
Vivos Inc.
Richland WA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc working with FX Masse completed nine certification training modules that are part of the certification training...
Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™
September 20, 2021 09:30 ET
|
Vivos Inc.
Richland WA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. is pleased to announce that it has submitted the IDE, Investigational Device Exemption for The Early Feasibility...
Vivos Inc Initiates Isopet® Therapy in Horses
June 24, 2021 09:30 ET
|
Vivos Inc.
Richland WA, June 24, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc announced that it has completed the first IsoPet® therapy on an equoid tumor. It was administered at the University...
Vivos Inc. Expands IsoPet® Trademark Protection
May 27, 2021 09:30 ET
|
Vivos Inc.
Richland, WA, May 27, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL). Vivos Inc. previously filed to extend its IsoPet® trademark protection internationally. We are pleased to report that the...
Vivos Inc Enhances Radiogel™ Manufacturing Process
May 24, 2021 09:30 ET
|
Vivos Inc.
Richland WA, May 24, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), During the past few months Vivos has made significant enhancements to the manufacturing process for Radiogel™. These...
Vivos Inc. Provides 2020 Recap and Outlines 2021 Objectives
January 28, 2021 09:30 ET
|
Vivos Inc.
Richland WA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2020 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2021, I think it is...